A patient support programme has shown that pharmacist interventions can improve adherence to diabetes medication by up to 61 per cent. The programme, which was a joint initiative by Celesio UK and MSD, was specifically designed to address patients’ individual concerns about their diabetes medication.

“We wanted to provide targeted support that was tailored to the individual needs of patients and we therefore segmented them according to their risk of non-adherence – high, medium and low – as well as their type of non-adherence – intentional versus unintentional,” says Laura Southall, service design manager for medicines adherence and patient support at Celesio.

Beliefs about a drug and the convenience of treatment or its complexity are important predictors of non-adherence. ‘Concern’ beliefs are about the adverse consequences of taking a drug, whereas ‘necessity’ beliefs are about the positive effects of a drug on someone’s health.

Previous research has found that for intentional non-adherers, ‘concerns’ play a more important role than ‘beliefs’ about the necessity of the drug for glucose lowering medications.

A total of 225 patients were recruited to the programme and were contacted via telephone and SMS text messages over a six-month period. The discontinuation rate was 8 per cent. The results show that:

• The 74 patients whose adherence was the most challenging when enrolled showed the greatest success, with average adherence increasing from 57.2 to 80.9 per cent
• Patients enrolled with low adherence ended the pilot with the highest overall adherence – up from 33.6 to 95.1 per cent (an improvement of 61.4 per cent)
• The 38 patients rated as medium adherence moved to the ‘high’ classification after an improvement of 27.7 per cent (up from 69.2 to 96.9 per cent).

“Our patient support programme has proven how effective a tailored and personalised pharmacist-led intervention can be in addressing reasons for non-adherence and driving positive outcomes,” says Laura Southall.

“Pharmacists are in an excellent position within the patient journey to make impactful interventions,” says Samuel Pygall, pharmacy strategy lead for MSD. “We are delighted to partner with Celesio on this initiative and hope that it is the beginning of collaboration that provides tailored projects that can really deliver change to healthcare provision in the community”.


Schools now able to purchase AAIs

Schools can now purchase adrenaline auto-injectors without a prescription for emergency use

NPA unveils national innovation programme

A series of service pilots, funded by the NPA, is seeking to demonstrate to commissioners what pharmacists can deliver


PSNC paints pessimistic picture for the future

The impact of the funding cuts in England is going to hit contractors hard in November, PSNC has warned

Are there barriers to women leaders in pharmacy?

With a number of pharmacy organisations with few or no women on their elected boards, what might be stopping more women ...

GSK launches Consumer Sensory Lab

Products such as toothpastes and cough syrups will be tested prior to market in a new Consumer Sensory Lab launched by G...